ARWR Stock Summary

• The ratio of debt to operating expenses for Arrowhead Pharmaceuticals Inc is higher than it is for about merely 0.37% of US stocks.
• With a year-over-year growth in debt of -100%, Arrowhead Pharmaceuticals Inc's debt growth rate surpasses merely 0% of about US stocks.
• As for revenue growth, note that ARWR's revenue has grown 945.67% over the past 12 months; that beats the revenue growth of 99.17% of US companies in our set.
• Stocks that are quantitatively similar to ARWR, based on their financial statements, market capitalization, and price volatility, are CRBP, MRUS, AFMD, VYGR, and MDWD.
• Visit ARWR's SEC page to see the company's official filings. To visit the company's web site, go to arrowheadpharma.com.